Many factors that patients with symptomatic PAD consider important and terms that they use to communicate are absent from consensus treatment guidelines. Areas of mismatch between patientand clinician-defined decision approaches and terminology represent opportunities for development of more patient-centered approaches to care and communication.
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Proposal of a Multicentric-Based Score for Graft Patency in Below- Objectives: This study retrospectively created a predictive score for primary patency (PP) in patients with critical limb ischemia (CLI) operated on with the use of a heparin-bonded expanded polytetrafluoroethylene (ePTFE) bypass graft (Hb-ePTFE) in a large multicenter registry.
Methods: Over a 13-year period, ending in December 2014, a Hb-ePTFE graft was implanted in 683 patients undergoing below-knee revascularization for CLI in seven Italian vascular hospitals. Data concerning these interventions were retrospectively collected in a multicenter registry with a dedicated database. Follow-up results were analyzed in terms of PP: univariate and multivariable analyses with Kaplan-Meier estimates were used to identify potential significant predictors of such end point at 3 years, and then a predictive risk score was constructed by dividing the b-coefficient of each significant predictor at multivariable analysis by 0.25 and by rounding off to the nearest integer value. A qualitative assessment of the Kaplan-Meier survival estimates for each integer score was performed, and subgroups of risk were stratified on the basis of the primary end point. Comparison between subgroups was performed with log-rank test.
Results: Median duration of follow-up was 34 months (range, 1-123; standard deviation, 27.8 months). Overall, estimated 3-year PP rate was 51.3% (standard error, 0.02). At multivariate analysis, female gender, reintervention following the failure of previous open or endovascular intervention, and the need for distal tibial anastomosis were predictors of poorer PP. The integer score ranged from 0 to 6. Kaplan-Meier analysis for PP in each score group identified four subgroups with significant differences at 3 years: score 0 (PP, 63%), score 2 (PP, 49%; P ¼ .003, log-rank 6.1, in comparison with score 0), score 4 (PP, 39%; P ¼ .05, log-rank 2.2, in comparison with score 2), and score 6 (PP, 25%; P ¼ . 01, log-rank 2.7 in comparison with score 4).
Conclusions: A category of patients with CLI treated with the indexed graft with excellent patency rates does exist, thus suggesting a primary role for Hb-ePTFE in such patients. A prospective validation of such a score is necessary.
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IP231. Kidney Transplant Increases the Risk of Ipsilateral Critical Limb Ischemia
Ziad Al Adas, Timothy Nypaver, Alex D. Shepard, Mitchell R. Weaver, Lauren Malinzak, Naushaba Khalid, Anita Patel, Loay Kabbani. Henry Ford Health System, Detroit, Mich
Objectives: End-stage renal disease is a known risk factor for peripheral arterial disease (PAD). Hypertension, hyperlipidemia, and diabetes, which are highly prevalent in renal transplant candidates, are independent risk factors for atherosclerosis and PAD. Renal transplantation is an invasive arterial procedure that may have effects on ipsilateral limb perfusion and/or progression of atherosclerotic disease. We hypothesized that the lower extremity ipsilateral to the side of the kidney transplant may be at increased risk for PAD complications.
Methods: Our transplant database was retrospectively queried for all kidney transplant patients who underwent subsequent lower extremity revascularization or amputation procedures. Patients with concomitant pancreatic transplants or bilateral renal transplants were excluded. Patient demographics, comorbidities, and discharge medications were collected, and data analysis was conducted on SPSS 22.0 software (IBM Corp, Armonk, NY).
Results: Between January 2004 and August 2016, 1214 patients received a renal transplant at our tertiary referral center. Of these, 25 patients (2%) had subsequent arterial revascularizations or amputations on either lower extremity. Average age was 55 years; 76% were male, 65% were African American, 92% had diabetes, 92% had hypertension, 44% had a history of coronary artery disease, and 72% were on aspirin or another antiplatelet agent. Eighteen patients had lower extremity vascular interventions (13 amputations and 5 revascularizations) ipsilateral to the transplanted kidney, and seven patients had contralateral vascular interventions (all amputations; P ¼ .043). The average interval between transplantation and subsequent vascular intervention was 27 months for the ipsilateral interventions and 39 months for the contralateral interventions (P ¼ .37).
Conclusions: Kidney transplantation is associated with an increased risk of ipsilateral lower extremity PAD requiring surgical intervention. Further studies are necessary to determine whether this represents a "steal" phenomenon vs progression of atherosclerosis distal to the transplanted kidney. Renal transplant patients should be monitored closely for the development of ischemic symptoms in the lower extremity ipsilateral to the transplanted kidney.
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Hybrid Approach for Aortoiliac TASC C and D Lesions
Paola Wiesel, Noemi Ventrella, Michele Tedesco, Giovanni Mastrangelo, Domenico Angiletta, Raffaele Pulli. University of Bari, Bari, Italy
Objectives: The recommended treatment of TASC (TransAtlantic InterSociety Consensus II) C and D iliac and femoral atherosclerotic disease is an open surgical approach, although in the last few years endovascular treatment is increasing. We hypothesized that a hybrid approach, combining iliac endovascular revascularization with common femoral artery endarterectomy, may improve long-term patency compared with angioplasty and stenting or with endarterectomy alone, reducing the morbidity rate.
Methods: We reviewed our clinical series of patients who underwent an endovascular or hybrid treatment from June 2015 to October 2016 for occlusive aortoiliac disease. Patient demographics, comorbidities, operative details, and risk factors were analyzed. Early and midterm results (12 months) were recorded in terms of primary and secondary patency, amputation, and survival. All patients underwent a double-antiplatelet therapy or anticoagulation combined with one antiplatelet drug. Immediate data were analyzed using the c
